Clustering trial information into one platform, such as DCCG Trials App, has shown to be useful for medical professionals treating patients with colorectal carcinoma in the Netherlands.Read more
Resveratrol significantly improves insulin sensitivity and glucose homeostasis in Caucasion men, and is well tolerated.Read more
JCTR is publishing a special issue on negative results obtained in ex vivo and in vivo research as well as in clinical trials. This special issue is guest edited by(Associate Director of the Yale-Hastings Program in Ethics & Health Policy; Departments of Psychology and Philosophy, Yale University, New Haven, Connecticut, United States) and (Department of Surgery, Academic Medical Center, University of Amsterdam).
The focus of the special issue is not why it is important to publish negative data. Instead, JCTR is giving the advocacy an actual follow-up by publishing robust studies with negative findings.
Please read the collection.
JCTR has prepared output style files for both EndNote and Mendeley users. Please contact ourto get a copy and make reference formatting easier.
Following the success of the previous events, Oxford Global is co-organizing two prestigious congresses in Boston this October: the Both congresses will take place on 23-24th October 2018 in Boston.and the .
The conferences feature key presentations including:
Single Cell Optical Analyses for Drug Discovery, Including Immunomodulatory Therapies, Andrea Pomerantz, Novartis; The Spatial Environment And Single-Cell Analysis, Guo-Cheng Yuan, Dana-Farber Cancer Institute and Transcriptomic Analysis In Immunology & Cancer Research, Virginia Savova, Sanofi.
NGS-based clinical diagnostics for comprehensive genomics profiling and liquid biopsies in molecular pathology by Sabah Kadri; Live Analysis Of Illumina Sequence Data While The Sequencer Is Still Running by Bernhard Renard, Robert Koch Institute and Clinical And Informatic Approaches To Genomic Screening, Matthew Lebo, Director Bioinformatics and Assistant Professor Pathology, Brigham and Woman's Hospital.
Read more details about speakers and agenda.
For further information regarding the conference programme, prices and possible discounts, please contact Angela Fernandez Saez onor call +44 (0)1865 248 455.
Dr. John E. Lewis is the co-founder and CEO of Nurish.Me. He is also a past full-time Associate Professor in the Department of Psychiatry and Behavioral Sciences at the University of Miami Miller School of Medicine and now remains as a Voluntary Associate Professor. He is a diplomate, faculty member, and advisor of the Medical Wellness Association.
Dr. Lewis has been the principal investigator of multiple nutrition, dietary supplement, exercise training, and medical device studies in the last 2 decades. Much of his research has included investigating the effects of interventions on a wide variety of outcomes, including immune and cognitive functioning, inflammation, physical fitness, nutrient status, quality of life, and mental health, in healthy adults and in those with Alzheimer’s, HIV, diabetes, chronic pain, and GI disorders, among others. He has co-authored more than 170 peer-reviewed scientific articles, has mentored many undergraduate, graduate, and medical students in exercise, nutrition, and health promotion, and has been an invited speaker at multiple international and national conferences, including aon the results of his work in Alzheimer's for TEDxMiami.
Prof. dr. Stuart S. Winter is Chief Research Officer at Children's Minnesota Research Institute, Professor of Pediatrics, and former Vice Chair of Pediatric Research at University of New Mexico, United States. With certification by the American Board of Pediatrics from 1994 onward, he is a practicing pediatric hematologist/oncologist with 24 years of experience. Prof. dr. Winter's translational focus is primarily directed towards the biology and classification of acute lymphoblastic leukemia (ALL) and the conduct of pediatric clinical trials.
rovide promo code "JCTR-biocytogen" to Biocytogen and receive 5% discount for your next gene editing project.is a leading gene targeted animal and services supplier globally. Biocytogen provides a traditonal ESC/HR platform as well as a cutting-edge Extreme Genome Editing (EGE®) system. P
(MD, PhD, Delft, the Netherlands) and (Associate Director of the Yale-Hastings Program in Ethics and Health Policy at Yale University, United States) are promoted to associate editors of the journal.